Among the various viral delivery systems discussed later, Gendicine, an adenoviral vector (AdV) delivering the p53 gene, has been successfully employed in the treatment of head and neck squamous cell carcinoma. Here, TP53 is linked to head and neck squamous cell carcinoma.